Ostersund Sjukhus

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Stroke1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Amgen1 trial
• Eli Lilly and Company1 trial

Closed trials

• Completed

  A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

  NCT04255433· Phase 3· Eli Lilly and Company· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source